Tongue Cancer Completed Phase 2 Trials for Ixabepilone (DB04845)

IndicationStatusPhase
DBCOND0029843 (Tongue Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00033618Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and NeckTreatment